NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled
NCT04861948 2022-10-04IBI188 Combination Therapy in Solid TumorsInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Terminated9 enrolled